HealthLynked Corp.
HLYK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $6 | $6 | $9 |
| % Growth | -47.4% | -2.3% | -36.3% | – |
| Cost of Goods Sold | $0 | $3 | $0 | $3 |
| Gross Profit | $3 | $2 | $5 | $6 |
| % Margin | 96.8% | 41% | 92.1% | 67.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5 | $7 | $8 | $8 |
| SG&A Expenses | $3 | $4 | $8 | $8 |
| Sales & Mktg Exp. | -$2 | -$3 | $0 | $0 |
| Other Operating Expenses | $5 | $3 | $3 | $3 |
| Operating Expenses | $8 | $7 | $11 | $11 |
| Operating Income | -$5 | -$4 | -$6 | -$5 |
| % Margin | -155.5% | -72.6% | -100.9% | -54.8% |
| Other Income/Exp. Net | -$1 | $1 | $1 | -$6 |
| Pre-Tax Income | -$6 | -$4 | -$8 | -$11 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$6 | -$1 | -$9 | -$10 |
| % Margin | -203.8% | -17.7% | -150.5% | -113.2% |
| EPS | -2.18 | -0.39 | -3.62 | -4.63 |
| % Growth | -459% | 89.2% | 21.8% | – |
| EPS Diluted | -2.18 | -0.39 | -3.62 | -4.63 |
| Weighted Avg Shares Out | 3 | 3 | 2 | 2 |
| Weighted Avg Shares Out Dil | 3 | 3 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $1 |
| EBITDA | -$4 | -$3 | -$7 | -$10 |
| % Margin | -145.1% | -48.1% | -120.3% | -107.1% |